- Clarendon scholar
I am a third-year DPhil student in Prof. Dani Prieto-Alhambrs's group. My thesis topic is on the safety and effectiveness of Covid-19 vaccines using real-world data.
Before joining the Pharmaco- and Device epidemiology team, I was a senior data analyst in The Division of Pharmaceutical Outcomes and Policy at the University of North Carolina at Chapel Hill in the United States.
I obtained my Bachelor's degree in Global Health at Wuhan University in China, and a Master of Health Science degree in Epidemiology at Johns Hopkins University Bloomberg School of Public Health in the United States.
Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom.
Burn E. et al, (2022), Nat commun, 13
Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain.
Burn E. et al, (2022), Nature communications, 13
Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US.
Li X. et al, (2022), Bmj, 379
Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.
Li X. et al, (2022), Bmj, 376
Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries.
Burn E. et al, (2022), Pharmacoepidemiol drug saf